Protective effect of intensive glucose lowering therapy on all-cause mortality, adjusted for treatment switching using G-estimation method, the ACCORD trial.

Shakiba, Maryam; Nazemipour, Maryam; Mansournia, Nasrin; Mansournia, Mohammad Ali

Shakiba, Maryam; Nazemipour, Maryam; Mansournia, Nasrin; Mansournia, Mohammad Ali.

Afiliação

Shakiba M; Cardiovascular Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Nazemipour M; Department of Biostatistics and Epidemiology, School of Health, Guilan University of Medical Sciences, Rasht, Iran.
Mansournia N; Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, PO Box: 14155-6446, Tehran, Iran.
Mansournia MA; Department of Endocrinology, AJA University of Medical Sciences, Tehran, Iran.

Sci Rep ; 13(1): 5833, 2023 04 10.

Article em En | MEDLINE | ID: mdl-37037931

Assuntos

Doenças Cardiovasculares; Diabetes Mellitus Tipo 2; Humanos; Glicemia; Doenças Cardiovasculares/etiologia; Diabetes Mellitus Tipo 2/tratamento farmacológico; Glucose/uso terapêutico; Hipoglicemiantes/uso terapêutico; Fatores de Risco; Troca de Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google